Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Efficacy and Safety of Sugammadex Versus Neostigmine in Reversing Neuromuscular Blockade in Adults." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433347/all/Efficacy_and_safety_of_sugammadex_versus_neostigmine_in_reversing_neuromuscular_blockade_in_adults.
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433347/all/Efficacy_and_safety_of_sugammadex_versus_neostigmine_in_reversing_neuromuscular_blockade_in_adults. Accessed January 16, 2025.
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433347/all/Efficacy_and_safety_of_sugammadex_versus_neostigmine_in_reversing_neuromuscular_blockade_in_adults
Efficacy and Safety of Sugammadex Versus Neostigmine in Reversing Neuromuscular Blockade in Adults [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433347/all/Efficacy_and_safety_of_sugammadex_versus_neostigmine_in_reversing_neuromuscular_blockade_in_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
ID - 433347
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433347/all/Efficacy_and_safety_of_sugammadex_versus_neostigmine_in_reversing_neuromuscular_blockade_in_adults
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -